These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10846424

  • 1. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R, Séra T, Pajor L, Thurzó L, Láng J, Csernay L, Pávics L.
    Orv Hetil; 2000 May 07; 141(19):1019-23. PubMed ID: 10846424
    [Abstract] [Full Text] [Related]

  • 2. Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
    de Klerk JM, van het Schip AD, Zonnenberg BA, van Dijk A, Quirijnen JM, Blijham GH, van Rijk PP.
    J Nucl Med; 1996 Feb 07; 37(2):244-9. PubMed ID: 8667053
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K, Franke WG, Kropp J, Koch R, Runge R, Hliscs R.
    Nuklearmedizin; 2000 Sep 07; 39(6):146-51. PubMed ID: 11057405
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
    Liepe K, Kropp J, Runge R, Kotzerke J.
    Br J Cancer; 2003 Aug 18; 89(4):625-9. PubMed ID: 12915868
    [Abstract] [Full Text] [Related]

  • 5. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K, Hliscs R, Kropp J, Grüning T, Runge R, Koch R, Knapp FF, Franke WG.
    Cancer Biother Radiopharm; 2000 Jun 18; 15(3):261-5. PubMed ID: 10941533
    [Abstract] [Full Text] [Related]

  • 6. Systemic radionuclide therapy in pain palliation.
    Liepe K, Runge R, Kotzerke J.
    Am J Hosp Palliat Care; 2005 Jun 18; 22(6):457-64. PubMed ID: 16323716
    [Abstract] [Full Text] [Related]

  • 7. Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
    Palmedo H, Bender H, Dierke-Dzierzon C, Carl UM, Risse J, Krebs D, Biersack HJ.
    Clin Nucl Med; 1999 Sep 18; 24(9):643-8. PubMed ID: 10478737
    [Abstract] [Full Text] [Related]

  • 8. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K, Hliscs R, Kropp J, Runge R, Knapp FF, Franke WG.
    J Nucl Med; 2003 Jun 18; 44(6):953-60. PubMed ID: 12791825
    [Abstract] [Full Text] [Related]

  • 9. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K, Runge R, Kotzerke J.
    J Cancer Res Clin Oncol; 2005 Jan 18; 131(1):60-6. PubMed ID: 15449184
    [Abstract] [Full Text] [Related]

  • 10. 186Re-HEDP for metastatic bone pain in breast cancer patients.
    Lam MG, de Klerk JM, van Rijk PP.
    Eur J Nucl Med Mol Imaging; 2004 Jun 18; 31 Suppl 1():S162-70. PubMed ID: 15118846
    [Abstract] [Full Text] [Related]

  • 11. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
    Schoeneich G, Palmedo H, Dierke-Dzierzon C, Müller SC, Biersack HJ.
    Scand J Urol Nephrol; 1997 Oct 18; 31(5):445-8. PubMed ID: 9406304
    [Abstract] [Full Text] [Related]

  • 12. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Küçük NO, Ibiş E, Aras G, Baltaci S, Ozalp G, Bedük Y, Canakci N, Soylu A.
    Ann Nucl Med; 2000 Aug 18; 14(4):239-45. PubMed ID: 11023023
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts.
    de Klerk JM, van Dieren EB, van het Schip AD, Hoekstra A, Zonnenberg BA, van Dijk A, Rutgers DH, Blijham GH, van Rijk PP.
    J Nucl Med; 1996 Jan 18; 37(1):38-41. PubMed ID: 8543998
    [Abstract] [Full Text] [Related]

  • 14. A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.
    Buffa FM, Flux GD, Guy MJ, O'Sullivan JM, McCready VR, Chittenden SJ, Dearnaley DP.
    Eur J Nucl Med Mol Imaging; 2003 Aug 18; 30(8):1114-24. PubMed ID: 12761596
    [Abstract] [Full Text] [Related]

  • 15. Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice.
    Zafeirakis A, Zissimopoulos A, Baziotis N, Limouris GS.
    Cancer Biother Radiopharm; 2009 Oct 18; 24(5):543-50. PubMed ID: 19877884
    [Abstract] [Full Text] [Related]

  • 16. Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer.
    de Klerk JM, Zonnenberg BA, van het Schip AD, van Dijk A, Han SH, Quirijnen JM, Blijham GH, van Rijk PP.
    Eur J Nucl Med; 1994 Oct 18; 21(10):1114-20. PubMed ID: 7530199
    [Abstract] [Full Text] [Related]

  • 17. The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
    Cheng A, Chen S, Zhang Y, Yin D, Dong M.
    Cancer Biother Radiopharm; 2011 Apr 18; 26(2):237-44. PubMed ID: 21539455
    [Abstract] [Full Text] [Related]

  • 18. [Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
    Hauswirth AE, Palmedo H, Dierke-Dzierzon C, Biersack HJ, Krebs D.
    Zentralbl Gynakol; 1998 Apr 18; 120(2):83-6. PubMed ID: 9531713
    [Abstract] [Full Text] [Related]

  • 19. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
    Sciuto R, Festa A, Pasqualoni R, Semprebene A, Rea S, Bergomi S, Maini CL.
    Breast Cancer Res Treat; 2001 Mar 18; 66(2):101-9. PubMed ID: 11437096
    [Abstract] [Full Text] [Related]

  • 20. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Pirayesh E, Amoui M, Mirzaee HR, Tabei F, Rakhsha A, Kalantari BA, Shafiei B, Assadi M, Asli IN.
    J Nucl Med Technol; 2013 Sep 18; 41(3):192-6. PubMed ID: 23918612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.